ホーム › 大腸癌 › ペンシルベニア › Philadelphia
Philadelphia、PAにおける大腸癌の臨床試験
Philadelphiaとその周辺地域（約30マイル以内）の拠点で、大腸癌に関する44件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
被験者募集中第2相
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23マイル先
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25マイル先
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22マイル先
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #98, Philadelphia
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
被験者募集中第3相
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Alliance Cancer Specialists at Main Line, Penn Wynne · 6マイル先
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
被験者募集中第1相
- GSK Investigational Site, Philadelphia
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
被験者募集中第1相
- Research Site, Philadelphia
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
被験者募集中第3相
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
被験者募集中第3相
- Fox Chase Cancer Center, Philadelphia
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
被験者募集中第1相
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
被験者募集中第1/2相
- Hospital of the University of Pennsylvania, Philadelphia
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
被験者募集中第3相
- University of Pennsylvania, Philadelphia
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
被験者募集中第3相
- Clinical Study Site, Philadelphia
- Clinical Study Site, Philadelphia
- Clinical Study Site, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
被験者募集中第1相
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
被験者募集中第2相
- Thomas Jefferson University - Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
被験者募集中第1/2相
- Children's Hospital of Philadelphia, Philadelphia
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
被験者募集中観察研究
- University of Pennsylvania, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
TCR1188-ABC Cells in KRAS-mutated Cancers
被験者募集中第1相
- University of Pennsylvania, Philadelphia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Thomas Jefferson University, Philadelphia
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
被験者募集中第1/2相
- University of Pennsylvania, Philadelphia
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
被験者募集中第1相
- Jefferson University Hospitals, Philadelphia
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
被験者募集中第2相
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
被験者募集中第2相
- Abramson Cancer Center at the University of Pennsylvania /ID# 275407, Philadelphia
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
被験者募集中第4相
- Jefferson Health, Philadelphia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
被験者募集中第1相
- Sidney Kimmel Cancer Center, Philadelphia
CT-95 in Advanced Cancers Associated With Mesothelin Expression
被験者募集中第1相
- University of Pennsylvania, Philadelphia
- Context Investigational Site, Philadelphia
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
被験者募集中第2相
- Alliance Cancer Specialists, Wynnewood · 7マイル先
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
被験者募集中第1/2相
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
被験者募集中第1相
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
被験者募集中第1相
- Sydney Kimmel Cancer Center, Philadelphia
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
被験者募集中第1/2相
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
被験者募集中第3相健康なボランティア歓迎
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23マイル先
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25マイル先
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
被験者募集中第1/2相
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
被験者募集中第1/2相
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University of Pennsylvania, Philadelphia
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
被験者募集中第1/2相
- University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
被験者募集中第4相
- Albert Einstein Healthcare Network, Philadelphia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
被験者募集中観察研究
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25マイル先
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
被験者募集中観察研究
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25マイル先
Collection of Samples USOPTIVAL Study
被験者募集中観察研究健康なボランティア歓迎
- University of Pennsylvania, Philadelphia
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
被験者募集中早期第1相
- Fox Chase Cancer Center, Philadelphia
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
被験者募集中第3相
- Perelman Center for Advanced Medicine, Philadelphia
他の都市における大腸癌の試験
- Houston, TX102件の研究
- New York City, NY78件の研究
- Nashville, TN69件の研究
- Boston, MA63件の研究
- Los Angeles, CA59件の研究
- Arlington, VA52件の研究
- St. Louis, MO50件の研究
- San Antonio, TX46件の研究
- Grand Rapids, MI40件の研究
- Baldwin Park, CA37件の研究
- Chicago, IL34件の研究
- Tampa, FL34件の研究
Philadelphiaにおける他の研究
- がん（全種類）59件の研究
- 乳がん56件の研究
- 非小細胞肺癌51件の研究
- 転移性癌46件の研究
- 前立腺がん44件の研究
- 卵巣がん44件の研究
- 肺がん36件の研究
- 急性骨髄性白血病34件の研究
- 心不全31件の研究
- 子宮内膜がん28件の研究
- うつ病26件の研究
- 膵臓がん26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。